Device-identified atrial fibrillation at pacing clinics. Should it guide anticoagulation?

Merinopoulos, Ioannis, Raphael, Claire E, Yardley, Alaina, Goonewardene, Manoj and Vassiliou, Vassilios S ORCID: https://orcid.org/0000-0002-4005-7752 (2016) Device-identified atrial fibrillation at pacing clinics. Should it guide anticoagulation? International Journal of Cardiology, 207. pp. 378-381. ISSN 1874-1754

Full text not available from this repository. (Request a copy)

Abstract

In recent years, there has been a significant increase in the number of devices implanted following improvement in their safety profile, extension of indications and reduction in cost. Although the reason remains largely the beneficial effect on heart rhythm stabilisation, implanted devices might also have additional advantages, notably identification of silent arrhythmia. Should clinicians therefore act on device-identified atrial fibrillation (AF) and should such identification be used to guide anticoagulation management? This review evaluates the current evidence on the management of device-identified asymptomatic AF.

Item Type:	Article
Additional Information:	Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Uncontrolled Keywords:	pacemaker,implanted device,atrial fibrillation,anticoagulation,stroke,thromboembolic risk
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	Pure Connector
Date Deposited:	10 Aug 2017 05:05
Last Modified:	19 Oct 2023 02:00
URI:	https://ueaeprints.uea.ac.uk/id/eprint/64442
DOI:	10.1016/j.ijcard.2016.01.040

Actions (login required)

View Item